Cardiology Stents - DES

A Contract Award Notice
by NATIONAL SERVICES SCOTLAND

Source
Find a Tender
Type
Framework (Goods)
Duration
not specified
Value
£3M
Sector
HEALTH
Published
16 Sep 2021
Delivery
not specified
Deadline
n/a

Concepts

Location

Scotland:

Geochart for 1 buyers and 16 suppliers

1 buyer

11 suppliers

Description

The Common Services Agency (more commonly known as National Services Scotland) (‘the Authority’) acting through its division Procurement, Commissioning & Facilities is undertaking this procurement of the supply and delivery of Cardiology Stents for use in Percutaneous Coronary Intervention procedures (Angioplasty) and related service and support (‘Products’) on behalf of all entities constituted pursuant to the National Health Service (Scotland) Act 1978, (i.e. all NHS Scotland Health Boards, Special Health Boards and the Authority or other NHS Organisation established pursuant to the NHS (Scotland) Act 1978), any integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014 (collectively hereafter referred to as ‘Participating Authorities’)

Lot Division

1 Workhorse Drug Eluting Stents

Provision of Workhorse Drug Eluting Stents for use in Cardiology. We envisage that a maximum of four (4) potential Framework Participants who scored the highest score for each lot (assessed against the award criteria) will be appointed to the Framework Agreement.
2 High Risk Bleed Drug Eluting Stents

Provision of High Risk Bleed Drug Eluting Stents for use in Cardiology. We envisage that a maximum of four (4) potential Framework Participants who scored the highest score for each lot (assessed against the award criteria) will be appointed to the Framework Agreement.
3 Niche Product Drug Eluting Stents

Provision of Niche Product Drug Eluting Stents for use in Cardiology. We envisage that a maximum of four (4) potential Framework Participants who scored the highest score for each lot (assessed against the award criteria) will be appointed to the Framework Agreement.

Award Detail

1 Abbott Laboratories (Maidenhead)
  • Workhorse Drug Eluting Stents
  • Reference: 023009-2021-1
  • Value: £2,590,000 [share]
  • Awarded to group of suppliers.
2 Biosensors (London)
  • Workhorse Drug Eluting Stents
  • Reference: 023009-2021-1
  • Value: £2,590,000 [share]
  • Awarded to group of suppliers.
3 Biotronik (Oxfordshire)
  • Workhorse Drug Eluting Stents
  • Reference: 023009-2021-1
  • Value: £2,590,000 [share]
  • Awarded to group of suppliers.
4 Boston Scientific (Herts)
  • Workhorse Drug Eluting Stents
  • Reference: 023009-2021-1
  • Value: £2,590,000 [share]
  • Awarded to group of suppliers.
5 Microport CRM (Chester)
  • Workhorse Drug Eluting Stents
  • Reference: 023009-2021-1
  • Value: £2,590,000 [share]
  • Awarded to group of suppliers.
6 Terumo (Bagshot)
  • Workhorse Drug Eluting Stents
  • Reference: 023009-2021-1
  • Value: £2,590,000 [share]
  • Awarded to group of suppliers.
7 Biosensors (London)
  • High Risk Bleed Drug Eluting Stents
  • Reference: 023009-2021-2
  • Value: £2,590,000 [share]
  • Awarded to group of suppliers.
8 Boston Scientific (Herts)
  • High Risk Bleed Drug Eluting Stents
  • Reference: 023009-2021-2
  • Value: £2,590,000 [share]
  • Awarded to group of suppliers.
9 Leib Medical (Belfast)
  • High Risk Bleed Drug Eluting Stents
  • Reference: 023009-2021-2
  • Value: £2,590,000 [share]
  • Awarded to group of suppliers.
10 Medtronic (Watford)
  • High Risk Bleed Drug Eluting Stents
  • Reference: 023009-2021-2
  • Value: £2,590,000 [share]
  • Awarded to group of suppliers.
11 Abbott Laboratories (Maidenhead)
  • Niche Product Drug Eluting Stents
  • Reference: 023009-2021-3
  • Value: £2,590,000 [share]
  • Awarded to group of suppliers.
12 Acrostak (High Wycombe)
  • Niche Product Drug Eluting Stents
  • Reference: 023009-2021-3
  • Value: £2,590,000 [share]
  • Awarded to group of suppliers.
13 B Braun Medical (Sheffield)
  • Niche Product Drug Eluting Stents
  • Reference: 023009-2021-3
  • Value: £2,590,000 [share]
  • Awarded to group of suppliers.
14 Biotronik (Oxfordshire)
  • Niche Product Drug Eluting Stents
  • Reference: 023009-2021-3
  • Value: £2,590,000 [share]
  • Awarded to group of suppliers.
15 Boston Scientific (Herts)
  • Niche Product Drug Eluting Stents
  • Reference: 023009-2021-3
  • Value: £2,590,000 [share]
  • Awarded to group of suppliers.
16 SMT (Galway)
  • Niche Product Drug Eluting Stents
  • Reference: 023009-2021-3
  • Value: £2,590,000 [share]
  • Awarded to group of suppliers.

Award Criteria

Quality 30
Cost 70

CPV Codes

  • 33140000 - Medical consumables
  • 33123220 - Cardio-angiography devices

Indicators

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. ** This contract is a re-tender of lots unable to be awarded on NP63520. This framework will be consolidated with NP63520 once awarded. The value in Section II.1.5 refers to the full duration of the framework including any extension options. This framework agreement will apply: Golden Jubilee Hospital (National Waiting Times Centre Board) NHS 24 NHS Ayrshire and Arran NHS Borders NHS Dumfries and Galloway NHS Education of Scotland NHS Fife NHS Forth Valley NHS Grampian NHS Greater Glasgow and Clyde NHS Health Scotland NHS Highland NHS Lanarkshire NHS Lothian NHS Orkney Healthcare Improvement Scotland NHS Shetland NHS Tayside NHS Western Isles. The Common Services Agency (more commonly known as National Services Scotland) (‘the Authority’) acting through its division National Procurement, is undertaking this procurement of (add description here...) (‘Products’) on behalf of all entities constituted pursuant to the National Health Service (Scotland) Act 1978, (i.e. all NHS Scotland Health Boards, Special Health Boards and the authority or other NHS Organisation established pursuant to the NHS (Scotland) Act 1978), any integrated Join Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014 (collectively hereafter referred to as ‘Participating Authorities’), where applicable. The buyer is using PCS-Tender to conduct this ITT exercise. The project code is - 19142 For more information http://www.publiccontractsscotland.gov.uk/info/infocentre.aspx?ID=2343 The Contracting Authority does not intend to include a sub-contract clause as part of community benefits (as per Section 25 of the Procurement Reform (Scotland) Act 2014) in this contract for the following reason: This framework will not be Sub-contracted. Community benefits are included in this requirement. For more information see: http://www.publiccontractsscotland.gov.uk/info/InfoCentre.aspx?ID=2361 A summary of the expected community benefits has been provided as follows: NHSS Community Benefits Marketplace. – Suppliers will be asked to commit to engaging with the Community Benefits Marketplace. (SC Ref:667389)

Reference

Domains